The development and progression of cancer is controlled by gene expression, often regulated through chromatin packaging. Heterochromatin protein 1 Hs␣ (HP1 Hs␣ ), one of three human HP1 family members, participates in heterochromatin formation and gene regulation. HP1Hs␣ possesses an amino-terminal chromodomain, which binds methylated lysine 9 of histone H3 (meK9 H3), and a carboxyl-terminal chromoshadow domain (CSD) that is required for dimerization and interaction with partner proteins. Mortality from breast cancer occurs by the spread of cancer cells to secondary sites within the body, a process called metastasis (1). Breast cancer cells must acquire several properties in order to disseminate from the primary tumor, including the ability to degrade and migrate through the extracellular matrix, a process called invasion (2). Invasion is one of the first steps in the metastatic cascade and is a strong indicator of tumor progression. Two classes of proteins have been identified that regulate metastasis progression: activators and suppressors (3). Metastasis activators are genes that promote metastasis, whereas metastasis suppressors inhibit metastasis. In contrast to tumor suppressors, metastasis suppressors do not affect growth of the primary tumor (3). Although several genes have been identified that regulate metastasis, clinically valuable predictive or prognostic molecular markers for metastasis have yet to be determined (4 -6). Currently, the best indicator for metastasis is lymph node micrometastases (4). However, microarray-based studies to identify transcription profiles that predict metastasis are in development (5, 7).In an attempt to identify genes with altered expression in breast cancer metastasis, a differential display analysis was performed comparing gene expression between poorly invasive nonmetastatic and highly invasive metastatic breast cancer cells (8). The mRNA encoding heterochromatin protein 1Hs␣ (HP1 Hs␣ ) 3 was found to be down-regulated (1.5-fold) in highly invasive metastatic breast cancer cell lines compared with poorly invasive nonmetastatic breast cancer cell lines (8, 9). Consistent with this reduction in mRNA, HP1Hs␣ protein levels showed an even larger disparity (7.1-fold) between the two types of breast cancer cells (9). HP1Hs␣ protein was also less abundant in metastatic tissues than in primary breast cancer tissues, suggesting that the down-regulation in highly invasive metastatic breast cancer cell lines recapitulate trends that were observed in clinical samples (9).HP1 is a highly conserved protein originally identified in Drosophila melanogaster as a component of chromatin near centromeres (10, 11). HP1 proteins are classically known to silence genes that have been juxtaposed to centric chromatin, and the degree of silencing is dependent on HP1 dosage (12, 13). Three HP1 family members have been identified in humans: HP1 Hs␣ , HP1 Hs , and HP1 Hs␥ . All HP1 family members consist of two conserved domains, the chromodomain (CD) and the chromoshadow domain (CSD), that are s...